Document Detail

Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension.
MedLine Citation:
PMID:  21160527     Owner:  NLM     Status:  Publisher    
The impact of target organ damage (TOD) clustering in hypertensive patients with established cardiovascular disease has not been clearly defined. Multicentre, observational and prospective study of 1054 consecutive patients with acute coronary syndromes (ACSs). The objective was describing the impact of TOD on first-year mortality. Ankle-brachial index (ABI), left ventricular hypertrophy and renal dysfunction were assessed during hospital stay. Hypertensive patients accounted for 80% of the cohort and had slightly higher mean age, higher prevalence of risk factors, previous cardiovascular disease and TOD. During follow-up, mean time 387.9 (7.2) days and median 382 (364.0-430.0) days, mortality rate tended to be higher in hypertensive patients (6.1 versus 3.5%; P=0.16). Cox regression survival analysis identified pathological ABI as the only TOD independently associated with mortality. When assessed globally, the presence of at least one TOD predicted mortality only in patients with hypertension and differences in mortality rate appeared very early in the follow-up. A linear increase in mortality rate was observed with the clustering of TOD: 2.0%, if no TOD was present, 7.6% in one TOD, 11.1% in two TODs and 20.0%, if three TODs were present. An increased risk in the combined end point of ischaemic events was observed in hypertensive patients without TOD (odds ratio (OR): 3.18; 95% confidence interval (CI): 1.31-7.70; P=0.01) and was still higher in patients with hypertension and TOD (OR: 4.61; 95% CI: 1.90-11.80; P<0.01). TOD predicts mortality and ischaemic events of hypertensive patients after ACS.Journal of Human Hypertension advance online publication, 16 December 2010; doi:10.1038/jhh.2010.109.
A Cordero; P Morillas; V Bertomeu-Gonzalez; J Quiles; P Mazón; J Guindo; F Soria; A Llácer; I Lekuona; J R Gonzalez-Juanatey; V Bertomeu
Related Documents :
17901767 - Role of 99mtc-tetrofosmin delayed scintigraphy and color doppler sonography in characte...
20305407 - Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a compari...
9085167 - Thyroid neoplasia and familial adenomatous polyposis/gardner's syndrome.
2999367 - Technetium thyroid uptake ratios in pediatric graves disease.
21380457 - N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
2587957 - Yeasts in blood cultures: impact of early therapy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-16
Journal Detail:
Title:  Journal of human hypertension     Volume:  -     ISSN:  1476-5527     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8811625     Medline TA:  J Hum Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Servicio de Cardiología, Hospital Universitario de San Juan, Alicante, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  RNA interference in the clinic: challenges and future directions.
Next Document:  Interaction between serum uric acid and triglycerides in relation to blood pressure.